Global artificial ventilation and anesthesia masks market is expected to reach USD 2,888.8 million by 2022, according to a new report by Grand View Research, Inc. Key factors attributing to market growth include rising number of operation and emergency room procedures coupled with growing demand novel products which can be used to carry out intubation process without removing the oxygen mask. Increase in the target disease has a direct impact on the number of operation room, emergency and intensive care procedures and is expected to boost usage rates of ventilation masks over the forecast period.
Increasing geriatric population is a major factor increasing the prevalence rate of several diseases. Additionally, growing prevalence of sleep apnea is one of the most significant growth drivers for these anesthesia and ventilation masks over the forecast period.
Browse Detail Report With TOC @
Further key findings from the report suggest:
In 2014, North America dominated the overall market with a share of more than 50%. Key factors attributing to its large share include presence of robust healthcare infrastructure, which includes hospitals, emergency and dental centers.
Furthermore, in the U.S., the Affordable Care Act is a key driver encouraging millions of patients to opt for surgical treatments and utilize other healthcare services, and as a result is expected to boost usage rates of artificial ventilation and anesthesia masks over the forecast period.
Asia Pacific is expected to be the fastest growing market over the forecast period. Key factors attributing to its high growth are increase in public and private healthcare expenditure to build new hospitals, improve reimbursement scenario which lead to improvement in overall healthcare indicators.
Additionally, large population affected with various diseases is expected to increase the number of emergency, ICU and operating room procedures and as a result are expected to increase usage rates in these markets.
Key players operating in the market include Phillips Respironics, ResMed, Fisher & Paykel, CareFusion, Ambu, Drager, and others. These companies have an extensive portfolio of ventilation and CPAP masks.
Additionally, emergence of new players with novel product offerings such as SuperNO2VA from RMDevices is expected change market dynamics due to its ability to carry out inhalation anesthesia, artificial ventilation and intubation procedure simultaneously.
Browse Some “Medical Devices” Market Research Reports
Tumor Ablation Market @
Retinal Implant Market 2022 @
Ambulatory Services Industry @
Table of Contents:
Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Scope & Assumptions
1.3 List of Data Sources
Chapter 2 Artificial Ventilation and Anesthesia Masks Industry Outlook
2.1 Market segmentation
2.2 Artificial ventilation and anesthesia masks market dynamics
2.3 Market driver analysis
2.4 Market restraint analysis
2.5 Lack of Patient Compliance
Chapter 3 Application Outlook
3.1 Artificial ventilation and anesthesia masks market share by application, 2014 & 2022
3.2 Operation Room
3.3 Intensive Care Units
3.4 Emergency Room
Chapter 4 Artificial Ventilation and Anesthesia Masks Regional Outlook
4.1 Artificial ventilation and anesthesia masks market share, by region, 2014 & 2022
4.2 North America
Request A Sample copy of This Report @
Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.
Company Name: Hexa Reports
Contact Person: Ryan Shaw
Address:Felton Office Plaza, 6265 Highway 9
Country: United States